In the past week, TLSA stock has gone up by 4.75%, with a monthly gain of 9.13% and a quarterly surge of 15.05%. The volatility ratio for the week is 4.20%, and the volatility levels for the last 30 days are 8.34% for Tiziana Life Sciences Ltd The simple moving average for the last 20 days is 4.74% for TLSA stock, with a simple moving average of 18.29% for the last 200 days.
Is It Worth Investing in Tiziana Life Sciences Ltd (NASDAQ: TLSA) Right Now?
The stock has a 36-month beta value of 0.64. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TLSA is 69.82M, and at present, short sellers hold a 0.39% of that float. On December 04, 2024, the average trading volume of TLSA was 233.13K shares.
TLSA) stock’s latest price update
Tiziana Life Sciences Ltd (NASDAQ: TLSA)’s stock price has plunge by 8.78relation to previous closing price of 0.91. Nevertheless, the company has seen a 4.75% surge in its stock price over the last five trading sessions. proactiveinvestors.com reported 2024-12-04 that Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has expanded its Phase 2 clinical trial evaluating intranasal foralumab for non-active secondary progressive multiple sclerosis (SPMS) to additional trial sites across the Northeast of the United States. The trial sites include highly-regarded institutions, including Yale University, Johns Hopkins University, Cornell University, University of Buffalo, University of Massachusetts, and Thomas Jefferson University.
Analysts’ Opinion of TLSA
Many brokerage firms have already submitted their reports for TLSA stocks, with B. Riley Securities repeating the rating for TLSA by listing it as a “Buy.” The predicted price for TLSA in the upcoming period, according to B. Riley Securities is $8 based on the research report published on December 22, 2020 of the previous year 2020.
TLSA Trading at 4.03% from the 50-Day Moving Average
After a stumble in the market that brought TLSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -43.11% of loss for the given period.
Volatility was left at 8.34%, however, over the last 30 days, the volatility rate increased by 4.20%, as shares surge +11.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.66% upper at present.
During the last 5 trading sessions, TLSA rose by +5.82%, which changed the moving average for the period of 200-days by +90.11% in comparison to the 20-day moving average, which settled at $0.9456. In addition, Tiziana Life Sciences Ltd saw 76.77% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for TLSA
The total capital return value is set at -2.58.
Currently, EBITDA for the company is -15.34 million with net debt to EBITDA at 0.06.
Conclusion
To sum up, Tiziana Life Sciences Ltd (TLSA) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
